Early Trough Levels and Antibodies Predict Safety and Success of Restarting Infliximab After Long Drug Holiday

被引：0
|
作者：
Baen, Filip J.
Drobne, David
Ballet, Vera
Cleynen, Isabelle
Compemolle, Griet
Riugeens, Paul J.
Van Assche, Gen A.
Gils, Ann
Venneire, Severine
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 46 条
  • [21] Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab
    Sorrentino, Dario
    Marino, Marco
    Dassopoulos, Themistocles
    Zarifi, Dimitra
    Del Bianco, Tiziana
    PLOS ONE, 2015, 10 (12):
  • [22] The Monitoring of Infliximab Levels at Early Stages Can Predict the Development of Anti-Infliximab Antibodies in a Cohort of Rheumatoid Arthritis Patients Treated with Infliximab
    Plasencia-Rodriguez, Chamaida
    Pascual-Salcedo, Dora
    Gema Bonilla, Maria
    Villalba, Alejandro
    Peiteado, Diana
    Nuno, Laura
    Aguado, Pilar
    Jurado, Teresa
    Martin-Mola, Emilio
    Balsa, Alejandro
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1098 - S1098
  • [23] Early Infliximab Trough Levels Predict the Long-term Efficacy of Infliximab in a Randomized Controlled Trial in Patients with Active Crohn?s Disease Comparing, between CT-P13 and Originator Infliximab
    Park, Jihye
    Cheon, Jae Hee
    Lee, Kang-Moon
    Kim, Young-Ho
    Ye, Byong Duk
    Eun, Chang Soo
    Kim, Sung Hyun
    Lee, Sun Hee
    Lee, Joon Ho
    Schreiber, Stefan
    GUT AND LIVER, 2023, 17 (03) : 430 - 440
  • [24] Predictors of sub-therapeutic infliximab or adalimumab trough levels and anti-drug antibodies and their influence on therapeutic decisions
    Goldberg, R.
    Beswick, L.
    Van Langenberg, D.
    Sally, B.
    Rosella, O.
    Gibson, P.
    Moore, G.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S223 - S223
  • [25] Anti-drug antibodies and low serum trough infliximab levels correlate with disease activity measures in spondyloarthritis patients on an as-needed infliximab treatment
    Patil, Abhishek
    Upadhyaya, Sundeep
    Dawar, Reetika
    Dadhaniya, Nikunjkumar
    Sood, Isha
    Gupta, Sirinder J.
    Handa, Rohini
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (09) : 1638 - 1643
  • [26] Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab
    Yanai, Henit
    Lichtenstein, Lev
    Assa, Amit
    Mazor, Yoav
    Weiss, Batia
    Levine, Arie
    Ron, Yulia
    Kopylov, Uri
    Bujanover, Yoram
    Rosenbach, Yoram
    Ungar, Bella
    Eliakim, Rami
    Chowers, Yehuda
    Shamir, Raanan
    Fraser, Gerald
    Dotan, Iris
    Ben-Horin, Shomron
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (03) : 522 - 530
  • [27] ANALYSIS OF REAL-LIFE INFLIXIMAB AND ADALIMUMAB DATA: DRUG SWITCHING AND FATE OF ANTIDRUG ANTIBODIES AND TROUGH LEVELS OVER TIME
    Hol, D.
    Valtanen, S.
    Havana, M.
    Kroger, L.
    Eklund, K.
    Jokiranta, T. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 600 - 600
  • [28] Post induction infliximab trough levels predict long-term endoscopic remission in paediatric patients with inflammatory bowel disease
    van Hoeve, K.
    Dreesen, E.
    Hoffman, I.
    Ferrante, M.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S362 - S363
  • [29] Early monitoring of infliximab serum trough levels predicts long-term therapy failure in patients with axial spondyloarthritis
    Martinez-Feito, A.
    Navarro-Compan, V
    Hernandez-Breijo, B.
    Olariaga-Merida, E.
    Peiteado, D.
    Villalba, A.
    Nuno, L.
    Monjo, I
    Diego, C.
    Pascual-Salcedo, D.
    Nozal, P.
    Balsa, A.
    Plasencia-Rodriguez, C.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2022, 51 (02) : 102 - 109
  • [30] Discriminating Between Response Types in Infliximab-Treated Patients With Crohn's Disease: Sensitivity and Specificity of Combined Assessment of Infliximab Trough Levels and Anti-Drug Antibodies
    Steenholdt, Casper
    Thomsen, Ole O.
    Brynskov, Jorn
    Bendtzen, Klaus
    Ainsworth, Mark A.
    GASTROENTEROLOGY, 2010, 138 (05) : S687 - S688
12345